Founded on genomic big data research, we have grown into a globally recognized leader through our AI-driven drug discovery platforms and supercomputing infrastructure.

The paradigm of drug discovery is rapidly changing. Traditional life sciences alone can no longer overcome the limitations we face. Interpretation and integrated approaches powered by AI innovation have become essential.

Through a portfolio of AI platforms—including DeepMatcher®—we are opening new possibilities in drug discovery and disease diagnosis, areas that have long posed significant challenges.

Guided by our core values of Innovation, Trust, Expansion, and Collaboration, we will continue to go beyond R&D to become a trusted partner in the global AI-driven drug discovery ecosystem.

With our proven technological expertise and practical, real-world applicability, we are committed to creating stable, sustainable growth that contributes to the betterment of humanity.